• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2101109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-07-13 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2200070 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2022-03-10 Green Cross China Biological Products Co Ltd view
CXSL2400412 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2024-06-26 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSL2200603 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-12-16 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2400278 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2101041 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-04-14 Shanxi Kangbao Biological Product Co Ltd view
CYSB2400062 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-05 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2101040 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-04-14 Shanxi Kangbao Biological Product Co Ltd view
CXSL2200013 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-01-12 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2200138 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-06-07 Shanghai RAAS Blood Products Co Ltd view
CYSB2200109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-04-29 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSL2200604 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-12-16 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2400267 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-10-10 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CXSL2200012 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-01-12 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2200137 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-06-07 Shanghai RAAS Blood Products Co Ltd view
CXSL2200229 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2022-05-27 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2400061 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2200067 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-03-01 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view